Losartan Potassium

Spezifikationen

124750-99-8CAS-Nummer

627-032-3EG-Nummer

potassium [2-butyl-5-chloro-3-[[4-[2-(1,2,3-triaza-4-azanidacyclopenta-2,5-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanolIUPAC-Name

C22H22ClKN6OChemische Formel

461 g/molMolekulargewicht

LOSARTAN POTASSIUM; 124750-99-8; Cozaar; Losacar; Losaprex; Losata; Tancin; Nu-Lotan; Aradois; Zaart; Presartan-50; Losartan monopotassium salt; MK-0954; MK0954; DuP 753; DuP-753; L-158086; DuP753; DU PONT-753; DTXSID3044209; 3ST302B24A; E-3340; 2-butyl-4-chloro-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-imidazole-5-methanol, monopotassium salt; Losatan Potassium; Losortan Potassium; Losartan Potatssium; 2-Butyl-4-chloro-1-((2'-(1H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-1H-imidazole-5-methanol, Monopotassium Salt; Potassium, Losartan; RefChem:55520; losartan potassium tablet; Monopotassium Salt, Losartan; Salt, Losartan Monopotassium; DTXCID1024209; LOSARTAN POTASSIUM 25 mg; LOSARTAN POTASSIUM 50 mg; LOSARTAN POTASSIUM 100 mg; Losartan Potassium Tablets, 25 mg; Losartan Potassium Tablets, 50 mg; Losartan Potassium Tablets, 100 mg; 658-044-7; Monopotassium 5-((4'-(2-butyl-4-chloro-5-hydroxymethyl-1H-imidazol-1-yl)methyl)biphenyl-2-yl)-1H-tetrazol-1-ide; losartan potassium salt; Lorzaar; Lortaan; Losartan Potassium (DuP 753); MK-954; 2-Butyl-4-chloro-1-(p-(o-1H-tetrazol-5-ylphenyl)benzyl)imidazole-5-methanol, monopotassium salt; potassium 5-(4'-((2-butyl-4-chloro-5-(hydroxymethyl)-1H-imidazol-1-yl)methyl)-[1,1'-biphenyl]-2-yl)tetrazol-1-ide; Lifezar; Lorzaan; Losacor; Tenopres; Lotim; Niten; Ocsaar; Neo Lotan; MK 954; Du Pont 753; Losartan potassium [USAN]; Covance; UNII-3ST302B24A; losartanpotassium; Losartan potassium [USAN:USP]; 1H-Imidazole-5-methanol, 2-butyl-4-chloro-1-((2'-(1H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-, monopotassium salt; 1H-Imidazole-5-methanol, 2-butyl-4-chloro-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-, monopotassium salt; Losartan potassium; Potassium 5-[4'-[[2-butyl-4-chloro-5-(hydroxymethyl)-1H-imidazol-1-yl]methyl]biphenyl-2-yl]tetrazol-1-ide; Losartan Potassium?; Cozaar (TN); ARBLI; MK 0954; Losartan potassium CRS; 1H-Imidazole-5-methanol, 2-butyl-4-chloro-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-, potassium salt (1:1); CHEMBL995; SCHEMBL42079; 124750-99-8 (Ka+); MLS001401407; potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,3-triaza-4-azanidacyclopenta-2,5-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol; Ex-89; orb1310826; orb3141289; LOSARTAN POTASSIUM [JAN]; Losartan potassium (JP18/USP); LOSARTAN POTASSIUM [HSDB]; HMS2051M12; HMS2090O22; HMS2235F20; HMS3369F08; HMS3393M12; LOSARTAN POTASSIUM [VANDF]; LOSARTAN POTASSIUM [MART.]; LOSARTAN POTASSIUM [USP-RS]; LOSARTAN POTASSIUM [WHO-DD]; MSK10415; AKOS015955543; AKOS025310168; AC-1072; CCG-100869; FL24945; Losartan potassium - Bio-X trade mark; Losartan potassium, analytical standard; NC00119; 2-Butyl-4-chloro-1-(2'-(tetrazol-5-yl)biphenyl-4-ylmethyl)-1H-imidazole-5-methanol potassium; LOSARTAN MONOPOTASSIUM SALT [MI]; LOSARTAN POTASSIUM [ORANGE BOOK]; LOSARTAN POTASSIUM [EP MONOGRAPH]; 2-Butyl-4-chloro-1-[[2'-(1H-tetrazol-5-yl)-1,1'-biphenyl-4-yl]methyl]imidazole-5-methanol Potassium Salt; BL164642; HYZAAR COMPONENT LOSARTAN POTASSIUM; LOSARTAN POTASSIUM [USP MONOGRAPH]; SMR000469593; L0232; NS00076270; D00357; AB01275507-01; SR-05000001514; SR-05000001514-1; Q27257991; Losartan Potassium Working Standard (Secondary Reference Standard); Losartan potassium, European Pharmacopoeia (EP) Reference Standard; Losartan potassium, United States Pharmacopeia (USP) Reference Standard; Losartan Potassium, Pharmaceutical Secondary Standard; Certified Reference Material; 2-Butyl-4-chloro-1-[[2'-(1H-tetrazol-5yl)[1,1'-biphenyl]-4-yl]methyl]-1H-imidazole-5-methanol potassium; Potassium 5-(4'-{[2-butyl-4-chloro-5-(hydroxymethyl)-1H-imidazol-1-yl]methyl}[1,1'-biphenyl]-2-yl)tetrazol-1-ide; Kali LosartanSynonyme